Sylios Corp. (fka UNGS)

[Akula42]

Agreed.

That is one of the reasons I have stayed in the stock after the Signifi deal fell through.

Two things of particular interest for me:

1. This following needs to play out and could be one of the reasons for the delay of otherwise consistent OTC reporting:

"ST. PETERSBURG, Fla. July 22, 2014 -- Sylios Corp (OTC Pink:UNGS), a holding company with operations engaged in the exploration and development oil and natural gas properties, investments in equities and corporate debt and the development of products utilized in the medical and recreational marijuana industry is pleased to announce that the Company's Board of Directors has retained the services of Enrique Nowogrodzki, CPA and CPA Services Corp to audit the Company's fiscal years 2011-2013."

http://www.sylios.com/news/press-releases/detail/424/sylios-corp-retains-auditor-to-regain-fully-reporting


2. Their web superstore which is still within committed range of deliever:

“Our Superstore is set to launch in November 2014 under the name of GCC Superstore. We have entered into re-seller agreements with some of the most innovate and crafty developers of smoking related accessories. The items we sell in our shop are hand-picked to offer you the widest selection, from grinders and rolling papers to one-of-a-kind glass pipes. We stay on top of what's new on the scene, and are always expanding our selection of cannabis seeds, vaporizers and concentrate smoking utensils.

Below are just a few examples of the GCC gear which will be available at the GCC Superstore in the coming month. Keep checking for the announcement of our Grand Opening date.”

http://www.greatercannabiscompany.com/E-commerce.html

In contrast to the two items above, I am not real confident about this one but would like to see a surprise here:

“Under the terms of the agreement, the Company will pay to Artemis a one-time licensing fee in the amount of $500,000.00 broken into tranches and based on development parameters. The Company has made the first payment towards the licensing agreement. Artemis will also receive a percentage of transaction fees generated on a monthly basis per unit. The Company will receive revenue generated directly from sales either though its website or sales staff, a royalty from sales generated through third party vendors/distributors, transaction based revenue and a percentage of any sub-licenses sold. In addition, the Company shall have the first right of refusal to purchase a license for the use of the same technology in other countries.
The Company's intended use of this product is solely as its first tier cannabis dispensing product. The product is scheduled to be completed and launched during the fourth quarter of 2014. As previously announced, the Company will launch its website dedicated to the new cannabis dispensing product in the very near future and anticipates presales to commence immediately thereafter.”

$UNGS